Serum Institute of India obtains emergency use authorisation in India for AstraZeneca's COVID-19 vaccine
|
06 January 2021 |
AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK
|
30 December 2020 |
AZD1222 Oxford Phase III trials interim analysis results published in The Lancet
|
08 December 2020 |
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
|
23 November 2020 |
FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
|
24 October 2020 |
COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials
|
09 October 2020 |
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
|
02 October 2020 |
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
|
12 September 2020 |
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
|
09 September 2020 |
Biopharma leaders unite to stand with science
|
08 September 2020 |